{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T13:45:11Z","timestamp":1779889511927,"version":"3.53.1"},"reference-count":93,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,5,15]],"date-time":"2017-05-15T00:00:00Z","timestamp":1494806400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2017,5,15]],"date-time":"2017-05-15T00:00:00Z","timestamp":1494806400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100015661","name":"UCB Pharma","doi-asserted-by":"crossref","award":["Unrestricted Research Grant"],"award-info":[{"award-number":["Unrestricted Research Grant"]}],"id":[{"id":"10.13039\/100015661","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["AI44257"],"award-info":[{"award-number":["AI44257"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s13075-017-1284-2","type":"journal-article","created":{"date-parts":[[2017,5,15]],"date-time":"2017-05-15T15:59:31Z","timestamp":1494863971000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Targeting CD22 with the monoclonal antibody epratuzumab modulates human B-cell maturation and cytokine production in response to Toll-like receptor 7 (TLR7) and B-cell receptor (BCR) signaling"],"prefix":"10.1186","volume":"19","author":[{"given":"Natalia V.","family":"Giltiay","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geraldine L.","family":"Shu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Shock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward A.","family":"Clark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,5,15]]},"reference":[{"issue":"4","key":"1284_CR1","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1177\/0961203312471576","volume":"22","author":"JH Anolik","year":"2013","unstructured":"Anolik JH. B cell biology: implications for treatment of systemic lupus erythematosus. Lupus. 2013;22(4):342\u20139.","journal-title":"Lupus"},{"issue":"5","key":"1284_CR2","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1186\/ar3433","volume":"13","author":"T Dorner","year":"2011","unstructured":"Dorner T, Giesecke C, Lipsky PE. Mechanisms of B cell autoimmunity in SLE. Arthritis Res Ther. 2011;13(5):243.","journal-title":"Arthritis Res Ther"},{"issue":"22","key":"1284_CR3","doi-asserted-by":"publisher","first-page":"2110","DOI":"10.1056\/NEJMra1100359","volume":"365","author":"GC Tsokos","year":"2011","unstructured":"Tsokos GC. Systemic lupus erythematosus. N Engl J Med. 2011;365(22):2110\u201321.","journal-title":"N Engl J Med"},{"issue":"6","key":"1284_CR4","doi-asserted-by":"publisher","first-page":"1762","DOI":"10.1002\/art.23498","volume":"58","author":"AM Jacobi","year":"2008","unstructured":"Jacobi AM, Reiter K, Mackay M, Aranow C, Hiepe F, Radbruch A, Hansen A, Burmester GR, Diamond B, Lipsky PE, et al. Activated memory B cell subsets correlate with disease activity in systemic lupus erythematosus: delineation by expression of CD27, IgD, and CD95. Arthritis Rheum. 2008;58(6):1762\u201373.","journal-title":"Arthritis Rheum"},{"issue":"10","key":"1284_CR5","doi-asserted-by":"publisher","first-page":"6624","DOI":"10.4049\/jimmunol.178.10.6624","volume":"178","author":"C Wei","year":"2007","unstructured":"Wei C, Anolik J, Cappione A, Zheng B, Pugh-Bernard A, Brooks J, Lee EH, Milner EC, Sanz I. A new population of cells lacking expression of CD27 represents a notable component of the B cell memory compartment in systemic lupus erythematosus. J Immunol. 2007;178(10):6624\u201333.","journal-title":"J Immunol"},{"issue":"2","key":"1284_CR6","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.jim.2010.06.009","volume":"363","author":"T Dorner","year":"2011","unstructured":"Dorner T, Jacobi AM, Lee J, Lipsky PE. Abnormalities of B cell subsets in patients with systemic lupus erythematosus. J Immunol Methods. 2011;363(2):187\u201397.","journal-title":"J Immunol Methods"},{"issue":"5","key":"1284_CR7","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1002\/art.10949","volume":"48","author":"AM Jacobi","year":"2003","unstructured":"Jacobi AM, Odendahl M, Reiter K, Bruns A, Burmester GR, Radbruch A, Valet G, Lipsky PE, Dorner T. Correlation between circulating CD27high plasma cells and disease activity in patients with systemic lupus erythematosus. Arthritis Rheum. 2003;48(5):1332\u201342.","journal-title":"Arthritis Rheum"},{"issue":"6","key":"1284_CR8","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1038\/nrrheum.2014.33","volume":"10","author":"FB Vincent","year":"2014","unstructured":"Vincent FB, Morand EF, Schneider P, Mackay F. The BAFF\/APRIL system in SLE pathogenesis. Nat Rev Rheumatol. 2014;10(6):365\u201373.","journal-title":"Nat Rev Rheumatol"},{"issue":"Suppl 4","key":"1284_CR9","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1186\/ar3918","volume":"14","author":"NV Giltiay","year":"2012","unstructured":"Giltiay NV, Chappell CP, Clark EA. B-cell selection and the development of autoantibodies. Arthritis Res Ther. 2012;14 Suppl 4:S1.","journal-title":"Arthritis Res Ther"},{"issue":"5","key":"1284_CR10","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1002\/art.39559","volume":"68","author":"SJ Fleischer","year":"2016","unstructured":"Fleischer SJ, Daridon C, Fleischer V, Lipsky PE, Dorner T. Enhanced Tyrosine phosphatase activity underlies dysregulated B Cell receptor signaling and promotes survival of human lupus B cells. Arthritis Rheumatol. 2016;68(5):1210\u201321.","journal-title":"Arthritis Rheumatol"},{"issue":"246","key":"1284_CR11","doi-asserted-by":"publisher","first-page":"246ra299","DOI":"10.1126\/scitranslmed.3009131","volume":"6","author":"XN Wu","year":"2014","unstructured":"Wu XN, Ye YX, Niu JW, Li Y, Li X, You X, Chen H, Zhao LD, Zeng XF, Zhang FC, et al. Defective PTEN regulation contributes to B cell hyperresponsiveness in systemic lupus erythematosus. Sci Transl Med. 2014;6(246):246ra299.","journal-title":"Sci Transl Med"},{"key":"1284_CR12","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/j.0105-2896.2005.00239.x","volume":"204","author":"IR Rifkin","year":"2005","unstructured":"Rifkin IR, Leadbetter EA, Busconi L, Viglianti G, Marshak-Rothstein A. Toll-like receptors, endogenous ligands, and systemic autoimmune disease. Immunol Rev. 2005;204:27\u201342.","journal-title":"Immunol Rev"},{"issue":"2","key":"1284_CR13","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.smim.2011.01.016","volume":"23","author":"NM Green","year":"2011","unstructured":"Green NM, Marshak-Rothstein A. Toll-like receptor driven B cell activation in the induction of systemic autoimmunity. Semin Immunol. 2011;23(2):106\u201312.","journal-title":"Semin Immunol"},{"issue":"1\u20133","key":"1284_CR14","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1007\/s12026-012-8270-1","volume":"53","author":"T Celhar","year":"2012","unstructured":"Celhar T, Magalhaes R, Fairhurst AM. TLR7 and TLR9 in SLE: when sensing self goes wrong. Immunol Res. 2012;53(1\u20133):58\u201377.","journal-title":"Immunol Res"},{"issue":"3\u20134","key":"1284_CR15","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.jaut.2009.10.001","volume":"33","author":"ML Santiago-Raber","year":"2009","unstructured":"Santiago-Raber ML, Baudino L, Izui S. Emerging roles of TLR7 and TLR9 in murine SLE. J Autoimmun. 2009;33(3\u20134):231\u20138.","journal-title":"J Autoimmun"},{"issue":"9","key":"1284_CR16","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1084\/jem.20050630","volume":"202","author":"CM Lau","year":"2005","unstructured":"Lau CM, Broughton C, Tabor AS, Akira S, Flavell RA, Mamula MJ, Christensen SR, Shlomchik MJ, Viglianti GA, Rifkin IR, et al. RNA-associated autoantigens activate B cells by combined B cell antigen receptor\/Toll-like receptor 7 engagement. J Exp Med. 2005;202(9):1171\u20137.","journal-title":"J Exp Med"},{"issue":"5780","key":"1284_CR17","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.1126\/science.1124978","volume":"312","author":"P Pisitkun","year":"2006","unstructured":"Pisitkun P, Deane JA, Difilippantonio MJ, Tarasenko T, Satterthwaite AB, Bolland S. Autoreactive B cell responses to RNA-related antigens due to TLR7 gene duplication. Science. 2006;312(5780):1669\u201372.","journal-title":"Science"},{"issue":"5","key":"1284_CR18","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1016\/j.immuni.2007.09.009","volume":"27","author":"JA Deane","year":"2007","unstructured":"Deane JA, Pisitkun P, Barrett RS, Feigenbaum L, Town T, Ward JM, Flavell RA, Bolland S. Control of toll-like receptor 7 expression is essential to restrict autoimmunity and dendritic cell proliferation. Immunity. 2007;27(5):801\u201310.","journal-title":"Immunity"},{"issue":"12","key":"1284_CR19","doi-asserted-by":"publisher","first-page":"2773","DOI":"10.1084\/jem.20122798","volume":"210","author":"NV Giltiay","year":"2013","unstructured":"Giltiay NV, Chappell CP, Sun X, Kolhatkar N, Teal TH, Wiedeman AE, Kim J, Tanaka L, Buechler MB, Hamerman JA, et al. Overexpression of TLR7 promotes cell-intrinsic expansion and autoantibody production by transitional T1 B cells. J Exp Med. 2013;210(12):2773\u201389.","journal-title":"J Exp Med"},{"issue":"3","key":"1284_CR20","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.immuni.2006.07.013","volume":"25","author":"SR Christensen","year":"2006","unstructured":"Christensen SR, Shupe J, Nickerson K, Kashgarian M, Flavell RA, Shlomchik MJ. Toll-like receptor 7 and TLR9 dictate autoantibody specificity and have opposing inflammatory and regulatory roles in a murine model of lupus. Immunity. 2006;25(3):417\u201328.","journal-title":"Immunity"},{"issue":"4","key":"1284_CR21","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.jaut.2009.11.001","volume":"34","author":"ML Santiago-Raber","year":"2010","unstructured":"Santiago-Raber ML, Dunand-Sauthier I, Wu T, Li QZ, Uematsu S, Akira S, Reith W, Mohan C, Kotzin BL, Izui S. Critical role of TLR7 in the acceleration of systemic lupus erythematosus in TLR9-deficient mice. J Autoimmun. 2010;34(4):339\u201348.","journal-title":"J Autoimmun"},{"issue":"12","key":"1284_CR22","doi-asserted-by":"publisher","first-page":"5786","DOI":"10.4049\/jimmunol.1202195","volume":"189","author":"SH Hwang","year":"2012","unstructured":"Hwang SH, Lee H, Yamamoto M, Jones LA, Dayalan J, Hopkins R, Zhou XJ, Yarovinsky F, Connolly JE, de Lafaille MA C, et al. B cell TLR7 expression drives anti-RNA autoantibody production and exacerbates disease in systemic lupus erythematosus-prone mice. J Immunol. 2012;189(12):5786\u201396.","journal-title":"J Immunol"},{"issue":"6","key":"1284_CR23","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1177\/0961203315622823","volume":"25","author":"YH Lee","year":"2016","unstructured":"Lee YH, Choi SJ, Ji JD, Song GG. Association between toll-like receptor polymorphisms and systemic lupus erythematosus: a meta-analysis update. Lupus. 2016;25(6):593\u2013601.","journal-title":"Lupus"},{"issue":"2","key":"1284_CR24","doi-asserted-by":"publisher","first-page":"R41","DOI":"10.1186\/ar3277","volume":"13","author":"A Kawasaki","year":"2011","unstructured":"Kawasaki A, Furukawa H, Kondo Y, Ito S, Hayashi T, Kusaoi M, Matsumoto I, Tohma S, Takasaki Y, Hashimoto H, et al. TLR7 single-nucleotide polymorphisms in the 3\u2032 untranslated region and intron 2 independently contribute to systemic lupus erythematosus in Japanese women: a case-control association study. Arthritis Res Ther. 2011;13(2):R41.","journal-title":"Arthritis Res Ther"},{"issue":"36","key":"1284_CR25","doi-asserted-by":"publisher","first-page":"15838","DOI":"10.1073\/pnas.1001337107","volume":"107","author":"N Shen","year":"2010","unstructured":"Shen N, Fu Q, Deng Y, Qian X, Zhao J, Kaufman KM, Wu YL, Yu CY, Tang Y, Chen JY, et al. Sex-specific association of X-linked Toll-like receptor 7 (TLR7) with male systemic lupus erythematosus. Proc Natl Acad Sci U S A. 2010;107(36):15838\u201343.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"1284_CR26","doi-asserted-by":"publisher","first-page":"4043","DOI":"10.4049\/jimmunol.174.7.4043","volume":"174","author":"IB Bekeredjian-Ding","year":"2005","unstructured":"Bekeredjian-Ding IB, Wagner M, Hornung V, Giese T, Schnurr M, Endres S, Hartmann G. Plasmacytoid dendritic cells control TLR7 sensitivity of naive B cells via type I IFN. J Immunol. 2005;174(7):4043\u201350.","journal-title":"J Immunol"},{"issue":"1","key":"1284_CR27","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.jaci.2008.09.018","volume":"123","author":"MC Glaum","year":"2009","unstructured":"Glaum MC, Narula S, Song D, Zheng Y, Anderson AL, Pletcher CH, Levinson AI. Toll-like receptor 7-induced naive human B-cell differentiation and immunoglobulin production. J Allergy Clin Immunol. 2009;123(1):224\u201330. e224.","journal-title":"J Allergy Clin Immunol"},{"issue":"7","key":"1284_CR28","doi-asserted-by":"publisher","first-page":"3035","DOI":"10.4049\/jimmunol.1402690","volume":"194","author":"N Simchoni","year":"2015","unstructured":"Simchoni N, Cunningham-Rundles C. TLR7- and TLR9-responsive human B cells share phenotypic and genetic characteristics. J Immunol. 2015;194(7):3035\u201344.","journal-title":"J Immunol"},{"issue":"3","key":"1284_CR29","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/S0952-7915(96)80128-2","volume":"8","author":"GM Doody","year":"1996","unstructured":"Doody GM, Dempsey PW, Fearon DT. Activation of B lymphocytes: integrating signals from CD19, CD22 and Fc gamma RIIb1. Curr Opin Immunol. 1996;8(3):378\u201382.","journal-title":"Curr Opin Immunol"},{"issue":"12","key":"1284_CR30","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1038\/nri955","volume":"2","author":"H Niiro","year":"2002","unstructured":"Niiro H, Clark EA. Regulation of B-cell fate by antigen-receptor signals. Nat Rev Immunol. 2002;2(12):945\u201356.","journal-title":"Nat Rev Immunol"},{"issue":"4","key":"1284_CR31","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/nri2056","volume":"7","author":"PR Crocker","year":"2007","unstructured":"Crocker PR, Paulson JC, Varki A. Siglecs and their roles in the immune system. Nat Rev Immunol. 2007;7(4):255\u201366.","journal-title":"Nat Rev Immunol"},{"key":"1284_CR32","first-page":"96","volume":"2","author":"J Jellusova","year":"2011","unstructured":"Jellusova J, Nitschke L. Regulation of B cell functions by the sialic acid-binding receptors siglec-G and CD22. Front Immunol. 2011;2:96.","journal-title":"Front Immunol"},{"issue":"3","key":"1284_CR33","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1046\/j.1365-3083.2001.00868.x","volume":"53","author":"L Nitschke","year":"2001","unstructured":"Nitschke L, Floyd H, Crocker PR. New functions for the sialic acid-binding adhesion molecule CD22, a member of the growing family of Siglecs. Scand J Immunol. 2001;53(3):227\u201334.","journal-title":"Scand J Immunol"},{"issue":"9","key":"1284_CR34","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1084\/jem.189.9.1513","volume":"189","author":"L Nitschke","year":"1999","unstructured":"Nitschke L, Floyd H, Ferguson DJ, Crocker PR. Identification of CD22 ligands on bone marrow sinusoidal endothelium implicated in CD22-dependent homing of recirculating B cells. J Exp Med. 1999;189(9):1513\u20138.","journal-title":"J Exp Med"},{"issue":"11","key":"1284_CR35","doi-asserted-by":"crossref","first-page":"4715","DOI":"10.4049\/jimmunol.150.11.4715","volume":"150","author":"EA Clark","year":"1993","unstructured":"Clark EA. CD22, a B cell-specific receptor, mediates adhesion and signal transduction. J Immunol. 1993;150(11):4715\u20138.","journal-title":"J Immunol"},{"issue":"3","key":"1284_CR36","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1111\/j.1365-2567.2007.02752.x","volume":"123","author":"JA Walker","year":"2008","unstructured":"Walker JA, Smith KG. CD22: an inhibitory enigma. Immunology. 2008;123(3):314\u201325.","journal-title":"Immunology"},{"issue":"5","key":"1284_CR37","doi-asserted-by":"publisher","first-page":"363","DOI":"10.3109\/08830185.2012.709890","volume":"31","author":"T Dorner","year":"2012","unstructured":"Dorner T, Shock A, Smith KG. CD22 and autoimmune disease. Int Rev Immunol. 2012;31(5):363\u201378.","journal-title":"Int Rev Immunol"},{"issue":"4","key":"1284_CR38","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1159\/000322375","volume":"3","author":"N Kawasaki","year":"2011","unstructured":"Kawasaki N, Rademacher C, Paulson JC. CD22 regulates adaptive and innate immune responses of B cells. J Innate Immun. 2011;3(4):411\u20139.","journal-title":"J Innate Immun"},{"issue":"6610","key":"1284_CR39","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1038\/384634a0","volume":"384","author":"KL Otipoby","year":"1996","unstructured":"Otipoby KL, Andersson KB, Draves KE, Klaus SJ, Farr AG, Kerner JD, Perlmutter RM, Law CL, Clark EA. CD22 regulates thymus-independent responses and the lifespan of B cells. Nature. 1996;384(6610):634\u20137.","journal-title":"Nature"},{"issue":"12","key":"1284_CR40","doi-asserted-by":"crossref","first-page":"4470","DOI":"10.4049\/jimmunol.136.12.4470","volume":"136","author":"B Dorken","year":"1986","unstructured":"Dorken B, Moldenhauer G, Pezzutto A, Schwartz R, Feller A, Kiesel S, Nadler LM. HD39 (B3), a B lineage-restricted antigen whose cell surface expression is limited to resting and activated human B lymphocytes. J Immunol. 1986;136(12):4470\u20139.","journal-title":"J Immunol"},{"issue":"6","key":"1284_CR41","doi-asserted-by":"publisher","first-page":"R204","DOI":"10.1186\/ar3179","volume":"12","author":"C Daridon","year":"2010","unstructured":"Daridon C, Blassfeld D, Reiter K, Mei HE, Giesecke C, Goldenberg DM, Hansen A, Hostmann A, Frolich D, Dorner T. Epratuzumab targeting of CD22 affects adhesion molecule expression and migration of B-cells in systemic lupus erythematosus. Arthritis Res Ther. 2010;12(6):R204.","journal-title":"Arthritis Res Ther"},{"issue":"13","key":"1284_CR42","doi-asserted-by":"publisher","first-page":"7469","DOI":"10.1073\/pnas.95.13.7469","volume":"95","author":"N Razi","year":"1998","unstructured":"Razi N, Varki A. Masking and unmasking of the sialic acid-binding lectin activity of CD22 (Siglec-2) on B lymphocytes. Proc Natl Acad Sci U S A. 1998;95(13):7469\u201374.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"50","key":"1284_CR43","doi-asserted-by":"publisher","first-page":"30066","DOI":"10.1074\/jbc.M115.691337","volume":"290","author":"MS Macauley","year":"2015","unstructured":"Macauley MS, Kawasaki N, Peng W, Wang SH, He Y, Arlian BM, McBride R, Kannagi R, Khoo KH, Paulson JC. Unmasking of CD22 co-receptor on germinal center B-cells occurs by alternative mechanisms in mouse and man. J Biol Chem. 2015;290(50):30066\u201377.","journal-title":"J Biol Chem"},{"issue":"10 Pt 2","key":"1284_CR44","first-page":"3982S","volume":"9","author":"J Carnahan","year":"2003","unstructured":"Carnahan J, Wang P, Kendall R, Chen C, Hu S, Boone T, Juan T, Talvenheimo J, Montestruque S, Sun J, et al. Epratuzumab, a humanized monoclonal antibody targeting CD22: characterization of in vitro properties. Clin Cancer Res. 2003;9(10 Pt 2):3982S\u201390S.","journal-title":"Clin Cancer Res"},{"key":"1284_CR45","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s13075-015-0561-1","volume":"17","author":"C Wei","year":"2015","unstructured":"Wei C, Jenks S, Sanz I. Polychromatic flow cytometry in evaluating rheumatic disease patients. Arthritis Res Ther. 2015;17:46.","journal-title":"Arthritis Res Ther"},{"issue":"16","key":"1284_CR46","doi-asserted-by":"publisher","first-page":"3051","DOI":"10.1200\/JCO.2003.01.082","volume":"21","author":"JP Leonard","year":"2003","unstructured":"Leonard JP, Coleman M, Ketas JC, Chadburn A, Ely S, Furman RR, Wegener WA, Hansen HJ, Ziccardi H, Eschenberg M, et al. Phase I\/II trial of epratuzumab (humanized anti-CD22 antibody) in indolent non-Hodgkin\u2019s lymphoma. J Clin Oncol. 2003;21(16):3051\u20139.","journal-title":"J Clin Oncol"},{"issue":"6","key":"1284_CR47","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1016\/j.molimm.2006.05.007","volume":"44","author":"J Carnahan","year":"2007","unstructured":"Carnahan J, Stein R, Qu Z, Hess K, Cesano A, Hansen HJ, Goldenberg DM. Epratuzumab, a CD22-targeting recombinant humanized antibody with a different mode of action from rituximab. Mol Immunol. 2007;44(6):1331\u201341.","journal-title":"Mol Immunol"},{"issue":"2","key":"1284_CR48","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/s12079-016-0322-1","volume":"10","author":"S Lumb","year":"2016","unstructured":"Lumb S, Fleischer SJ, Wiedemann A, Daridon C, Maloney A, Shock A, Dorner T. Engagement of CD22 on B cells with the monoclonal antibody epratuzumab stimulates the phosphorylation of upstream inhibitory signals of the B cell receptor. J Cell Commun Signal. 2016;10(2):143\u201351.","journal-title":"J Cell Commun Signal"},{"issue":"3","key":"1284_CR49","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1002\/art.37818","volume":"65","author":"N Sieger","year":"2013","unstructured":"Sieger N, Fleischer SJ, Mei HE, Reiter K, Shock A, Burmester GR, Daridon C, Dorner T. CD22 ligation inhibits downstream B cell receptor signaling and Ca(2+) flux upon activation. Arthritis Rheum. 2013;65(3):770\u20139.","journal-title":"Arthritis Rheum"},{"issue":"5","key":"1284_CR50","first-page":"953","volume":"3","author":"T Dorner","year":"2007","unstructured":"Dorner T, Goldenberg DM. Targeting CD22 as a strategy for treating systemic autoimmune diseases. Ther Clin Risk Manag. 2007;3(5):953\u20139.","journal-title":"Ther Clin Risk Manag"},{"issue":"4","key":"1284_CR51","doi-asserted-by":"publisher","first-page":"R129","DOI":"10.1186\/ar2018","volume":"8","author":"SD Steinfeld","year":"2006","unstructured":"Steinfeld SD, Tant L, Burmester GR, Teoh NK, Wegener WA, Goldenberg DM, Pradier O. Epratuzumab (humanised anti-CD22 antibody) in primary Sjogren\u2019s syndrome: an open-label phase I\/II study. Arthritis Res Ther. 2006;8(4):R129.","journal-title":"Arthritis Res Ther"},{"issue":"3","key":"1284_CR52","doi-asserted-by":"publisher","first-page":"R74","DOI":"10.1186\/ar1942","volume":"8","author":"T Dorner","year":"2006","unstructured":"Dorner T, Kaufmann J, Wegener WA, Teoh N, Goldenberg DM, Burmester GR. Initial clinical trial of epratuzumab (humanized anti-CD22 antibody) for immunotherapy of systemic lupus erythematosus. Arthritis Res Ther. 2006;8(3):R74.","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"1284_CR53","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1136\/annrheumdis-2012-202760","volume":"73","author":"DJ Wallace","year":"2014","unstructured":"Wallace DJ, Kalunian K, Petri MA, Strand V, Houssiau FA, Pike M, Kilgallen B, Bongardt S, Barry A, Kelley L, et al. Efficacy and safety of epratuzumab in patients with moderate\/severe active systemic lupus erythematosus: results from EMBLEM, a phase IIb, randomised, double-blind, placebo-controlled, multicentre study. Ann Rheum Dis. 2014;73(1):183\u201390.","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"1284_CR54","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1136\/ard.2007.075762","volume":"67","author":"AM Jacobi","year":"2008","unstructured":"Jacobi AM, Goldenberg DM, Hiepe F, Radbruch A, Burmester GR, Dorner T. Differential effects of epratuzumab on peripheral blood B cells of patients with systemic lupus erythematosus versus normal controls. Ann Rheum Dis. 2008;67(4):450\u20137.","journal-title":"Ann Rheum Dis"},{"issue":"17","key":"1284_CR55","doi-asserted-by":"publisher","first-page":"3020","DOI":"10.1182\/blood-2012-12-473744","volume":"122","author":"EA Rossi","year":"2013","unstructured":"Rossi EA, Goldenberg DM, Michel R, Rossi DL, Wallace DJ, Chang CH. Trogocytosis of multiple B-cell surface markers by CD22 targeting with epratuzumab. Blood. 2013;122(17):3020\u20139.","journal-title":"Blood"},{"key":"1284_CR56","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1186\/s13075-015-0686-2","volume":"17","author":"V Fleischer","year":"2015","unstructured":"Fleischer V, Sieber J, Fleischer SJ, Shock A, Heine G, Daridon C, Dorner T. Epratuzumab inhibits the production of the proinflammatory cytokines IL-6 and TNF-alpha, but not the regulatory cytokine IL-10, by B cells from healthy donors and SLE patients. Arthritis Res Ther. 2015;17:185.","journal-title":"Arthritis Res Ther"},{"issue":"12","key":"1284_CR57","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1016\/j.autrev.2015.07.013","volume":"14","author":"T Dorner","year":"2015","unstructured":"Dorner T, Shock A, Goldenberg DM, Lipsky PE. The mechanistic impact of CD22 engagement with epratuzumab on B cell function: Implications for the treatment of systemic lupus erythematosus. Autoimmun Rev. 2015;14(12):1079\u201386.","journal-title":"Autoimmun Rev"},{"issue":"3\u20134","key":"1284_CR58","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/0022-1759(76)90050-8","volume":"12","author":"A Saxon","year":"1976","unstructured":"Saxon A, Feldhaus J, Robins RA. Single step separation of human T and B cells using AET treated srbc rosettes. J Immunol Methods. 1976;12(3\u20134):285\u20138.","journal-title":"J Immunol Methods"},{"issue":"6","key":"1284_CR59","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.4049\/jimmunol.140.6.1791","volume":"140","author":"A Pezzutto","year":"1988","unstructured":"Pezzutto A, Rabinovitch PS, Dorken B, Moldenhauer G, Clark EA. Role of the CD22 human B cell antigen in B cell triggering by anti-immunoglobulin. J Immunol. 1988;140(6):1791\u20135.","journal-title":"J Immunol"},{"issue":"1","key":"1284_CR60","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.smim.2007.12.006","volume":"20","author":"I Sanz","year":"2008","unstructured":"Sanz I, Wei C, Lee FE, Anolik J. Phenotypic and functional heterogeneity of human memory B cells. Semin Immunol. 2008;20(1):67\u201382.","journal-title":"Semin Immunol"},{"issue":"6","key":"1284_CR61","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1309\/AJCPDQNP2U5DZHVV","volume":"136","author":"MK Kjeldsen","year":"2011","unstructured":"Kjeldsen MK, Perez-Andres M, Schmitz A, Johansen P, Boegsted M, Nyegaard M, Gaihede M, Bukh A, Johnsen HE, Orfao A, et al. Multiparametric flow cytometry for identification and fluorescence activated cell sorting of five distinct B-cell subpopulations in normal tonsil tissue. Am J Clin Pathol. 2011;136(6):960\u20139.","journal-title":"Am J Clin Pathol"},{"issue":"3","key":"1284_CR62","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1038\/nri3795","volume":"15","author":"SL Nutt","year":"2015","unstructured":"Nutt SL, Hodgkin PD, Tarlinton DM, Corcoran LM. The generation of antibody-secreting plasma cells. Nat Rev Immunol. 2015;15(3):160\u201371.","journal-title":"Nat Rev Immunol"},{"issue":"47","key":"1284_CR63","doi-asserted-by":"publisher","first-page":"39789","DOI":"10.1074\/jbc.M112.383000","volume":"287","author":"NM Green","year":"2012","unstructured":"Green NM, Moody KS, Debatis M, Marshak-Rothstein A. Activation of autoreactive B cells by endogenous TLR7 and TLR3 RNA ligands. J Biol Chem. 2012;287(47):39789\u201399.","journal-title":"J Biol Chem"},{"issue":"3","key":"1284_CR64","doi-asserted-by":"crossref","first-page":"720","DOI":"10.4049\/jimmunol.138.3.720","volume":"138","author":"EA Clark","year":"1987","unstructured":"Clark EA, Shu G. Activation of human B cell proliferation through surface Bp35 (CD20) polypeptides or immunoglobulin receptors. J Immunol. 1987;138(3):720\u20135.","journal-title":"J Immunol"},{"issue":"6","key":"1284_CR65","doi-asserted-by":"crossref","first-page":"2948","DOI":"10.4049\/jimmunol.132.6.2948","volume":"132","author":"K Yoshizaki","year":"1984","unstructured":"Yoshizaki K, Nakagawa T, Fukunaga K, Tseng LT, Yamamura Y, Kishimoto T. Isolation and characterization of B cell differentiation factor (BCDF) secreted from a human B lymphoblastoid cell line. J Immunol. 1984;132(6):2948\u201354.","journal-title":"J Immunol"},{"key":"1284_CR66","first-page":"135","volume":"254","author":"T Kishimoto","year":"1989","unstructured":"Kishimoto T, Taga T, Yamasaki K, Matsuda T, Tang B, Muraguchi A, Horii Y, Suematsu S, Hirata Y, Yawata H, et al. Normal and abnormal regulation of human B cell differentiation by a new cytokine, BSF2\/IL-6. Adv Exp Med Biol. 1989;254:135\u201343.","journal-title":"Adv Exp Med Biol"},{"issue":"1","key":"1284_CR67","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1084\/jem.20081571","volume":"206","author":"O Dienz","year":"2009","unstructured":"Dienz O, Eaton SM, Bond JP, Neveu W, Moquin D, Noubade R, Briso EM, Charland C, Leonard WJ, Ciliberto G, et al. The induction of antibody production by IL-6 is indirectly mediated by IL-21 produced by CD4+ T cells. J Exp Med. 2009;206(1):69\u201378.","journal-title":"J Exp Med"},{"issue":"3","key":"1284_CR68","doi-asserted-by":"publisher","first-page":"e17739","DOI":"10.1371\/journal.pone.0017739","volume":"6","author":"D Eto","year":"2011","unstructured":"Eto D, Lao C, DiToro D, Barnett B, Escobar TC, Kageyama R, Yusuf I, Crotty S. IL-21 and IL-6 are critical for different aspects of B cell immunity and redundantly induce optimal follicular helper CD4 T cell (Tfh) differentiation. PLoS One. 2011;6(3):e17739.","journal-title":"PLoS One"},{"issue":"4","key":"1284_CR69","doi-asserted-by":"publisher","first-page":"e0153059","DOI":"10.1371\/journal.pone.0153059","volume":"11","author":"S Jain","year":"2016","unstructured":"Jain S, Park G, Sproule TJ, Christianson GJ, Leeth CM, Wang H, Roopenian DC, Morse 3rd HC. Interleukin 6 accelerates mortality by promoting the progression of the systemic lupus erythematosus-like disease of BXSB.Yaa mice. PLoS One. 2016;11(4):e0153059.","journal-title":"PLoS One"},{"issue":"12","key":"1284_CR70","doi-asserted-by":"publisher","first-page":"8180","DOI":"10.4049\/jimmunol.179.12.8180","volume":"179","author":"VL Bryant","year":"2007","unstructured":"Bryant VL, Ma CS, Avery DT, Li Y, Good KL, Corcoran LM, de Waal MR, Tangye SG. Cytokine-mediated regulation of human B cell differentiation into Ig-secreting cells: predominant role of IL-21 produced by CXCR5+ T follicular helper cells. J Immunol. 2007;179(12):8180\u201390.","journal-title":"J Immunol"},{"issue":"1","key":"1284_CR71","doi-asserted-by":"crossref","first-page":"117","DOI":"10.4049\/jimmunol.147.1.117","volume":"147","author":"M Linker-Israeli","year":"1991","unstructured":"Linker-Israeli M, Deans RJ, Wallace DJ, Prehn J, Ozeri-Chen T, Klinenberg JR. Elevated levels of endogenous IL-6 in systemic lupus erythematosus. A putative role in pathogenesis. J Immunol. 1991;147(1):117\u201323.","journal-title":"J Immunol"},{"issue":"4","key":"1284_CR72","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.immuni.2015.04.005","volume":"42","author":"EC Rosser","year":"2015","unstructured":"Rosser EC, Mauri C. Regulatory B cells: origin, phenotype, and function. Immunity. 2015;42(4):607\u201312.","journal-title":"Immunity"},{"issue":"173","key":"1284_CR73","doi-asserted-by":"publisher","first-page":"173ra123","DOI":"10.1126\/scitranslmed.3005407","volume":"5","author":"F Flores-Borja","year":"2013","unstructured":"Flores-Borja F, Bosma A, Ng D, Reddy V, Ehrenstein MR, Isenberg DA, Mauri C. CD19\u2009+\u2009CD24hiCD38hi B cells maintain regulatory T cells while limiting TH1 and TH17 differentiation. Sci Transl Med. 2013;5(173):173ra123.","journal-title":"Sci Transl Med"},{"issue":"1","key":"1284_CR74","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.immuni.2009.11.009","volume":"32","author":"PA Blair","year":"2010","unstructured":"Blair PA, Norena LY, Flores-Borja F, Rawlings DJ, Isenberg DA, Ehrenstein MR, Mauri C. CD19(+)CD24(hi)CD38(hi) B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic Lupus Erythematosus patients. Immunity. 2010;32(1):129\u201340.","journal-title":"Immunity"},{"issue":"10","key":"1284_CR75","doi-asserted-by":"publisher","first-page":"2686","DOI":"10.1002\/eji.201040673","volume":"40","author":"JD Bouaziz","year":"2010","unstructured":"Bouaziz JD, Calbo S, Maho-Vaillant M, Saussine A, Bagot M, Bensussan A, Musette P. IL-10 produced by activated human B cells regulates CD4(+) T-cell activation in vitro. Eur J Immunol. 2010;40(10):2686\u201391.","journal-title":"Eur J Immunol"},{"key":"1284_CR76","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1186\/s13075-015-0687-1","volume":"17","author":"JH Sim","year":"2015","unstructured":"Sim JH, Kim HR, Chang SH, Kim IJ, Lipsky PE, Lee J. Autoregulatory function of interleukin-10-producing pre-naive B cells is defective in systemic lupus erythematosus. Arthritis Res Ther. 2015;17:190.","journal-title":"Arthritis Res Ther"},{"issue":"7","key":"1284_CR77","doi-asserted-by":"publisher","first-page":"2121","DOI":"10.1002\/eji.201344341","volume":"44","author":"BS Liu","year":"2014","unstructured":"Liu BS, Cao Y, Huizinga TW, Hafler DA, Toes RE. TLR-mediated STAT3 and ERK activation controls IL-10 secretion by human B cells. Eur J Immunol. 2014;44(7):2121\u20139.","journal-title":"Eur J Immunol"},{"issue":"2","key":"1284_CR78","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1084\/jem.183.2.547","volume":"183","author":"CL Law","year":"1996","unstructured":"Law CL, Sidorenko SP, Chandran KA, Zhao Z, Shen SH, Fischer EH, Clark EA. CD22 associates with protein tyrosine phosphatase 1C, Syk, and phospholipase C-gamma(1) upon B cell activation. J Exp Med. 1996;183(2):547\u201360.","journal-title":"J Exp Med"},{"issue":"23","key":"1284_CR79","doi-asserted-by":"publisher","first-page":"17420","DOI":"10.1074\/jbc.M001892200","volume":"275","author":"JC Poe","year":"2000","unstructured":"Poe JC, Fujimoto M, Jansen PJ, Miller AS, Tedder TF. CD22 forms a quaternary complex with SHIP, Grb2, and Shc. A pathway for regulation of B lymphocyte antigen receptor-induced calcium flux. J Biol Chem. 2000;275(23):17420\u20137.","journal-title":"J Biol Chem"},{"issue":"47","key":"1284_CR80","doi-asserted-by":"publisher","first-page":"44315","DOI":"10.1074\/jbc.M105446200","volume":"276","author":"KL Otipoby","year":"2001","unstructured":"Otipoby KL, Draves KE, Clark EA. CD22 regulates B cell receptor-mediated signals via two domains that independently recruit Grb2 and SHP-1. J Biol Chem. 2001;276(47):44315\u201322.","journal-title":"J Biol Chem"},{"issue":"4","key":"1284_CR81","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1182\/blood.V94.4.1382","volume":"94","author":"JM Tuscano","year":"1999","unstructured":"Tuscano JM, Riva A, Toscano SN, Tedder TF, Kehrl JH. CD22 cross-linking generates B-cell antigen receptor-independent signals that activate the JNK\/SAPK signaling cascade. Blood. 1999;94(4):1382\u201392.","journal-title":"Blood"},{"key":"1284_CR82","unstructured":"Maloney AHD, Rapecki S, Fossati G, Lumb S, Rosen D, Putta S, Wale N, Spellmeyer D, Cesano A, Hawtin R and Shock A. Epratuzumab induces broad inhibition of B cell receptor proximal signaling but has opposing effects on distal signaling in B cell subsets: a profile of effects on functional immune signaling by single cell network profiling. Arthritis Rheum. 2014;66(Suppl 10):S1255\u20136"},{"issue":"4","key":"1284_CR83","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1016\/j.molimm.2013.05.241","volume":"56","author":"J Luo","year":"2013","unstructured":"Luo J, Niu X, Liu H, Zhang M, Chen M, Deng S. Up-regulation of transcription factor Blimp1 in systemic lupus erythematosus. Mol Immunol. 2013;56(4):574\u201382.","journal-title":"Mol Immunol"},{"issue":"7","key":"1284_CR84","doi-asserted-by":"crossref","first-page":"3096","DOI":"10.4049\/jimmunol.154.7.3096","volume":"154","author":"N Chaouchi","year":"1995","unstructured":"Chaouchi N, Vazquez A, Galanaud P, Leprince C. B cell antigen receptor-mediated apoptosis. Importance of accessory molecules CD19 and CD22, and of surface IgM cross-linking. J Immunol. 1995;154(7):3096\u2013104.","journal-title":"J Immunol"},{"issue":"1","key":"1284_CR85","doi-asserted-by":"publisher","first-page":"199","DOI":"10.4161\/19420862.2014.979081","volume":"7","author":"CH Chang","year":"2015","unstructured":"Chang CH, Wang Y, Gupta P, Goldenberg DM. Extensive crosslinking of CD22 by epratuzumab triggers BCR signaling and caspase-dependent apoptosis in human lymphoma cells. MAbs. 2015;7(1):199\u2013211.","journal-title":"MAbs"},{"issue":"3","key":"1284_CR86","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1038\/nri3814","volume":"15","author":"K Basso","year":"2015","unstructured":"Basso K, Dalla-Favera R. Germinal centres and B cell lymphomagenesis. Nat Rev Immunol. 2015;15(3):172\u201384.","journal-title":"Nat Rev Immunol"},{"issue":"2","key":"1284_CR87","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1002\/art.39856","volume":"69","author":"ME Clowse","year":"2017","unstructured":"Clowse ME, Wallace DJ, Furie RA, Petri MA, Pike MC, Leszczynski P, Neuwelt CM, Hobbs K, Keiserman M, Duca L, et al. Efficacy and safety of epratuzumab in moderately to severely active systemic lupus erythematosus: results from two phase III randomized, double-blind, placebo-controlled trials. Arthritis Rheumatol. 2017;69(2):362\u201375.","journal-title":"Arthritis Rheumatol"},{"issue":"10","key":"1284_CR88","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1177\/0961203316652492","volume":"25","author":"MA Mahieu","year":"2016","unstructured":"Mahieu MA, Strand V, Simon LS, Lipsky PE, Ramsey-Goldman R. A critical review of clinical trials in systemic lupus erythematosus. Lupus. 2016;25(10):1122\u201340.","journal-title":"Lupus"},{"issue":"10","key":"1284_CR89","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1093\/rheumatology\/32.10.876","volume":"32","author":"D Isenberg","year":"1993","unstructured":"Isenberg D, Spellerberg M, Williams W, Griffiths M, Stevenson F. Identification of the 9G4 idiotope in systemic lupus erythematosus. Br J Rheumatol. 1993;32(10):876\u201382.","journal-title":"Br J Rheumatol"},{"issue":"7","key":"1284_CR90","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1038\/ni.3175","volume":"16","author":"CM Tipton","year":"2015","unstructured":"Tipton CM, Fucile CF, Darce J, Chida A, Ichikawa T, Gregoretti I, Schieferl S, Hom J, Jenks S, Feldman RJ, et al. Diversity, cellular origin and autoreactivity of antibody-secreting cell population expansions in acute systemic lupus erythematosus. Nat Immunol. 2015;16(7):755\u201365.","journal-title":"Nat Immunol"},{"key":"1284_CR91","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s13075-015-0580-y","volume":"17","author":"Z Mahmood","year":"2015","unstructured":"Mahmood Z, Muhammad K, Schmalzing M, Roll P, Dorner T, Tony HP. CD27-IgD- memory B cells are modulated by in vivo interleukin-6 receptor (IL-6R) blockade in rheumatoid arthritis. Arthritis Res Ther. 2015;17:61.","journal-title":"Arthritis Res Ther"},{"issue":"10","key":"1284_CR92","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/j.mad.2009.08.003","volume":"130","author":"G Colonna-Romano","year":"2009","unstructured":"Colonna-Romano G, Bulati M, Aquino A, Pellicano M, Vitello S, Lio D, Candore G, Caruso C. A double-negative (IgD-CD27-) B cell population is increased in the peripheral blood of elderly people. Mech Ageing Dev. 2009;130(10):681\u201390.","journal-title":"Mech Ageing Dev"},{"key":"1284_CR93","doi-asserted-by":"crossref","unstructured":"Craig P. Chappell, Kevin E. Draves, Edward A. Clark. \u00a0CD22 is required for formation of memory B cell precursors within germinal centers. PLOS ONE. 2017;12(3):e0174661.","DOI":"10.1371\/journal.pone.0174661"}],"container-title":["Arthritis Research & Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-017-1284-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13075-017-1284-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-017-1284-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,24]],"date-time":"2024-06-24T04:02:47Z","timestamp":1719201767000},"score":1,"resource":{"primary":{"URL":"https:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/s13075-017-1284-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,15]]},"references-count":93,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["1284"],"URL":"https:\/\/doi.org\/10.1186\/s13075-017-1284-2","relation":{},"ISSN":["1478-6362"],"issn-type":[{"value":"1478-6362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5,15]]},"assertion":[{"value":"18 October 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"91"}}